# Polypeptide Laboratories France – FDA Inspection, Jul 4, 2024

Source: https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-france/e18fc9be-2980-4e11-a3ef-554bf9e25eeb
Source feed: FDA_Inspections

> FDA inspection 1280973 of Polypeptide Laboratories France, July 04, 2024. Classification: Voluntary Action Indicated (VAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1280973
- Company Name: Polypeptide Laboratories France
- Inspection Date: 2024-07-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1107059 - 2019-09-12
- FDA Inspection 884800 - 2014-05-23
- FDA Inspection 620930 - 2009-09-16

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/mra-v-millarw/ea28ecad-65ef-4cbe-9f4b-fa460dcef90f)

Company: https://www.keypedia.com/companies/polypeptide-laboratories-france/a335ec84-dffa-4fa6-91ef-e7597d35c228

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c